Titre:
  • Antiviral activity of TMC435 monotherapy in patients infected with HCV genotypes 2-6: TMC435-C202, a phase IIa, open-label study.
Auteur:Moreno, Christophe; Berg, Thomas; Tanwandee, Tawesak; Thongsawat, Satawat; Van Vlierberghe, Hans; Zeuzem, Stefan; Lenz, Oliver; Peeters, Monika P.; Sekar, Vanitha; De Smedt, Goedele
Informations sur la publication:Journal of hepatology, 56, 6, page (1247-1253)
Statut de publication:Publié, 2012-06
Sujet CREF:Sciences bio-médicales et agricoles
Mots-clés:Antiviral
Genotype
HCV
Monotherapy
TMC435
MeSH keywords:Adolescent
Adult
Aged
Antiviral Agents -- therapeutic use
Female
Genotype
Hepacivirus -- classification -- genetics
Hepatitis C -- drug therapy -- virology
Heterocyclic Compounds, 3-Ring -- adverse effects -- pharmacokinetics -- therapeutic use
Humans
Male
Middle Aged
Sulfonamides -- adverse effects -- pharmacokinetics -- therapeutic use
Note générale:Clinical Trial, Phase II
Journal Article
Multicenter Study
SCOPUS: ar.j
Langue:Anglais
Identificateurs:urn:issn:0168-8278
info:doi/10.1016/j.jhep.2011.12.033
info:pii/S0168-8278(12)00116-X
info:scp/84861188748
info:pmid/22326470